🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/10/2015 38,65 40,04 37,00 39,59 +0,79% 7,87% 3.045.100
01/10/2015 36,18 39,53 35,60 39,28 +22,33% 10,86% 8.555.500
30/09/2015 31,35 33,45 31,00 32,11 +0,66% 7,81% 2.528.200
29/09/2015 33,60 34,92 31,15 31,90 -5,09% 11,22% 1.972.300
28/09/2015 36,22 36,30 32,76 33,61 -7,33% 9,77% 2.004.500
25/09/2015 39,34 39,70 35,40 36,27 -6,71% 10,93% 1.585.200
24/09/2015 38,11 39,29 36,80 38,88 +0,83% 6,53% 1.477.700
23/09/2015 38,92 39,70 38,02 38,56 -0,82% 4,32% 628.900
22/09/2015 38,58 39,23 37,91 38,88 -0,89% 3,42% 1.127.700
21/09/2015 40,38 41,47 38,67 39,23 -1,75% 6,93% 2.118.200
18/09/2015 39,22 40,98 39,14 39,93 -0,03% 4,69% 2.297.600
17/09/2015 37,37 40,14 36,71 39,94 +7,14% 9,18% 1.968.500
16/09/2015 38,34 38,66 36,46 37,28 -2,28% 5,74% 887.000
15/09/2015 36,72 38,47 36,69 38,15 +3,75% 4,85% 1.404.100
14/09/2015 36,06 37,73 36,02 36,77 +2,31% 4,74% 1.390.400
11/09/2015 34,22 36,00 34,05 35,94 +4,33% 5,70% 918.500
10/09/2015 33,15 34,72 33,01 34,45 +3,55% 5,16% 838.400
09/09/2015 34,34 34,58 33,07 33,27 -2,20% 4,40% 980.700
08/09/2015 34,58 34,60 33,25 34,02 +0,62% 3,90% 1.089.400
04/09/2015 33,50 34,46 32,29 33,81 +0,84% 6,48% 1.185.500
03/09/2015 37,00 37,29 33,45 33,53 -9,11% 10,38% 1.557.900
02/09/2015 35,67 36,92 35,02 36,89 +4,77% 5,33% 1.068.700
01/09/2015 34,82 35,84 34,20 35,21 -1,37% 4,71% 1.260.700
31/08/2015 36,42 37,39 35,50 35,70 -2,70% 5,19% 1.680.200
28/08/2015 36,13 37,19 35,62 36,69 +1,27% 4,35% 1.689.500
27/08/2015 34,36 36,88 34,30 36,23 +6,03% 7,51% 2.309.700
26/08/2015 34,30 34,33 32,01 34,17 +4,88% 6,76% 2.558.700
25/08/2015 34,29 34,45 32,47 32,58 -0,91% 5,77% 1.621.700
24/08/2015 32,00 35,05 31,50 32,88 -2,89% 11,09% 2.369.800
21/08/2015 33,43 35,58 32,60 33,86 -1,34% 8,91% 2.114.900